OrganaBio launches new division to meet growing demand for decentralized clinical trial support

OrganaBio, the Contract Technology Development and Manufacturing Organization (CTDMO) specializing in solutions for cell and immunotherapy development, today announces the official launch of Cell Processing and Cryopreservation (CPC) Services, a new division of OrganaBio.

SPACE-H Accelerator to Explore Astronaut Disease Treatment in Space

What You Should Know: – NaNotics LLC, a biopharmaceutical company developing NaNots® – novel subtractive nanoparticles that treat disease by capturing and clearing pathogenic molecules from

September 27, 2024

New 5-minute cognitive test boosts dementia care in diverse elderly populations

The 5-Cog tool significantly enhances dementia diagnosis and care for older adults in primary care, especially among Black and Hispanic communities, by being culturally sensitive

June 7, 2024

NK cells’ role in cancer therapy resistance unveiled

Activated T cells that carry a certain marker protein on their surface are controlled by natural killer (NK) cells, another cell type of the immune

May 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.